Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 578165, 11 pages
http://dx.doi.org/10.1155/2013/578165
Research Article

An Aqueous Extract of Radix Astragali, Angelica sinensis, and Panax notoginseng Is Effective in Preventing Diabetic Retinopathy

1Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China
2Division of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China
3Central Laboratory, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China

Received 18 December 2012; Revised 6 March 2013; Accepted 6 March 2013

Academic Editor: William Cho

Copyright © 2013 Dehong Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. I. Liou, “Diabetic retinopathy: role of inflammation and potential therapies for anti-inflammation,” World Journal of Diabetes, vol. 1, no. 1, pp. 12–18, 2010. View at Publisher · View at Google Scholar
  2. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S. E. Bursell, and A. P. Adamis, “Leukocyte-mediated endothelial cell injury and death in the diabetic retina,” American Journal of Pathology, vol. 158, no. 1, pp. 147–152, 2001. View at Google Scholar · View at Scopus
  5. S. Schroder, W. Palinski, and G. W. Schmid-Schonbein, “Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy,” American Journal of Pathology, vol. 139, no. 1, pp. 81–100, 1991. View at Google Scholar · View at Scopus
  6. T. Murakami, E. A. Felinski, and D. A. Antonetti, “Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability,” Journal of Biological Chemistry, vol. 284, no. 31, pp. 21036–21046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Durham and I. M. Herman, “Microvascular modifications in diabetic retinopathy,” Current Diabetes Reports, vol. 11, no. 4, pp. 253–264, 2011. View at Publisher · View at Google Scholar
  8. L. W. Kelly, C. A. Barden, J. S. Tiedeman, and D. L. Hatchell, “Alterations in viscosity and filterability of whole blood and blood cell subpopulations in diabetic cats,” Experimental Eye Research, vol. 56, no. 3, pp. 341–347, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kimura, T. Toyota, M. Kakizaki, M. Kudo, K. Takebe, and Y. Goto, “Impaired insulin secretion in the spontaneous diabetes rats,” Tohoku Journal of Experimental Medicine, vol. 137, no. 4, pp. 453–459, 1982. View at Google Scholar · View at Scopus
  10. S. M. Abdel-Halim, A. Guenifi, H. Luthman, V. Grill, S. Efendic, and C. G. Ostenson, “Impact of diabetic inheritance on glucose tolerance and insulin-secretion in spontaneously diabetic GK-Wistar rats,” Diabetes, vol. 43, no. 2, pp. 281–288, 1994. View at Google Scholar · View at Scopus
  11. C. G. Ostenson, A. Khan, S. M. Abdel-Halim et al., “Abnormalin insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat,” Diabetologia, vol. 36, no. 1, pp. 3–8, 1993. View at Google Scholar · View at Scopus
  12. C. D. Agardh, E. Agardh, H. Zhang, and C. G. Östenson, “Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina,” Journal of Diabetes and its Complications, vol. 11, no. 3, pp. 158–162, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Omri, F. Behar-Cohen, Y. de Kozak et al., “Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model,” American Journal of Pathology, vol. 179, no. 2, pp. 942–953, 2011. View at Publisher · View at Google Scholar
  14. H. Sone, Y. Kawakami, Y. Okuda et al., “Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes,” Diabetologia, vol. 40, no. 6, pp. 726–730, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Yatoh, M. Mizutani, T. Yokoo et al., “Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 1, pp. 38–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Zhao, G. Su, X. Xiao, E. Hao, X. Zhu, and J. Ren, “Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis,” Toxicology Letters, vol. 182, no. 1–3, pp. 29–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. H. Shon and K. S. Nam, “Protective effect of Astragali Radix extract on Interleukin 1β-induced Infammation in human amnion,” Phytotherapy Research, vol. 17, no. 9, pp. 1016–1020, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ryu, E. H. Kim, M. Chun et al., “Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 184–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. H. Shon, J. H. Kim, and K. S. Nam, “Effect of Astragali radix extract on lipopolysaccharide-induced inflammation in human amnion,” Biological & Pharmaceutical Bulletin, vol. 25, no. 1, pp. 77–80, 2002. View at Google Scholar · View at Scopus
  20. R. L. C. Hoo, J. Y. L. Wong, C. F. Qiao, A. Xu, H. X. Xu, and K. S. L. Lam, “The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity,” Nutrition and Metabolism, vol. 7, article 67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. B. Jiang, J. D. Qiu, L. H. Yang, J. P. He, G. W. Smith, and H. Q. Li, “Therapeutic effects of astragalus polysaccharides on inflammation and synovial apoptosis in rats with adjuvant-induced arthritis,” International Journal of Rheumatic Diseases, vol. 13, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. C. Law, K. K. Auyeung, L. Y. Chan, and J. K. Ko, “Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells,” BMC Complementary and Alternative Medicine, vol. 12, article 160, 2012. View at Publisher · View at Google Scholar
  23. C. Yang, S. Niu, L. Yu, S. Zhu, J. Zhu, and Q. Zhu, “The aqueous extract of Angelica sinensis, a popular Chinese herb, inhibits wear debris-induced inflammatory osteolysis in mice,” Journal of Surgical Research, vol. 176, no. 2, pp. 476–483, 2012. View at Publisher · View at Google Scholar
  24. C. Han and J. Guo, “Antibacterial and anti-inflammatory activity of traditional Chinese herb pairs, Angelica sinensis and Sophora flavescens,” Inflammation, vol. 35, no. 3, pp. 913–919, 2012. View at Publisher · View at Google Scholar
  25. W. W. Chao, Y. H. Hong, M. L. Chen, and B. F. Lin, “Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-κB trans-activation activity and LPS-induced inflammation,” Journal of Ethnopharmacology, vol. 129, no. 2, pp. 244–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Zhang, S. Chen, X. Deng, X. Yang, and X. Huang, “Danggui-Buxue-Tang decoction has an anti-inflammatory effect in diabetic atherosclerosis rat model,” Diabetes Research and Clinical Practice, vol. 74, no. 2, pp. 194–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Lv, Z. Zhao, Y. Chen et al., “The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 284963, 11 pages, 2012. View at Publisher · View at Google Scholar
  28. J. S. Fan, D. N. Liu, G. Huang et al., “Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression,” Journal of Ethnopharmacology, vol. 142, no. 3, pp. 732–738, 2012. View at Publisher · View at Google Scholar
  29. N. Ning, X. Dang, C. Bai, C. Zhang, and K. Wang, “Panax notoginsenoside produces neuroprotective effects in rat model of acute spinal cord ischemia-reperfusion injury,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 504–512, 2012. View at Publisher · View at Google Scholar
  30. N. Wang, J. B. Wan, S. W. Chan et al., “Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion,” Chinese Medicine, vol. 6, article 37, 2011. View at Publisher · View at Google Scholar
  31. Y. Liu, H. G. Zhang, Y. Jia, and X. H. Li, “Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits,” Biological and Pharmaceutical Bulletin, vol. 33, no. 8, pp. 1324–1330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. B. Wan, S. M. Y. Lee, J. D. Wang et al., “Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-α-induced endothelial adhesion molecule expression and monocyte adhesion,” Journal of Agricultural and Food Chemistry, vol. 57, no. 15, pp. 6692–6697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. W. Jung, U. K. Seo, J. H. Kim, K. H. Leem, and Y. K. Park, “Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-κB signaling pathway in murine macrophages,” Journal of Ethnopharmacology, vol. 122, no. 2, pp. 313–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. G. Zhang, H. G. Zhang, G. Y. Zhang et al., “Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 10, pp. 1238–1244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Rhule, S. Navarro, J. R. Smith, and D. M. Shepherd, “Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells,” Journal of Ethnopharmacology, vol. 106, no. 1, pp. 121–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Dou, Y. Lu, T. Shen et al., “Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice,” Cellular Physiology and Biochemistry, vol. 29, no. 5-6, pp. 875–882, 2012. View at Google Scholar
  37. J. Angulo, C. Peiro, T. Romacho et al., “Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate,” European Journal of Pharmacology, vol. 667, no. 1–3, pp. 153–159, 2011. View at Publisher · View at Google Scholar
  38. D. Skondra, K. Noda, L. Almulki et al., “Characterization of azurocidin as a permeability factor in the Retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown,” Investigative Ophthalmology and Visual Science, vol. 49, no. 2, pp. 726–731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. S. Kern and R. L. Engerman, “Vascular lesions in diabetes are distributed non-uniformly within the retina,” Experimental Eye Research, vol. 60, no. 5, pp. 545–549, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Kowluru and S. Odenbach, “Effect of long-term administration of α-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats,” Diabetes, vol. 53, no. 12, pp. 3233–3238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Miyamoto, S. Khosrof, S. E. Bursell et al., “Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10836–10841, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Y. Yang, J. Wang, Y. Zhao et al., “Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 231–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Rangasamy, P. G. McGuire, and A. Das, “Diabetic retinopathy and inflammation: novel therapeutic targets,” Middle East African Journal of Ophthalmology, vol. 19, no. 1, pp. 52–59, 2012. View at Publisher · View at Google Scholar
  44. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression,” The FASEB Journal, vol. 16, no. 3, pp. 438–440, 2002. View at Google Scholar · View at Scopus
  45. P. Pakneshan, A. E. Birsner, I. Adini, C. M. Becker, and R. J. D'Amato, “Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs,” Investigative Ophthalmology and Visual Science, vol. 49, no. 9, pp. 3909–3913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. M. V. Van Hecke, J. M. Dekker, G. Nijpels et al., “Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study,” Diabetologia, vol. 48, no. 7, pp. 1300–1306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Carmo, J. G. Cunha-Vaz, A. P. Carvalho, and M. C. Lopes, “Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability,” Nitric Oxide, vol. 4, no. 6, pp. 590–596, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. S. E. Moss, R. Klein, and B. E. K. Klein, “The 14-year incidence of visual loss in a diabetic population,” Ophthalmology, vol. 105, no. 6, pp. 998–1003, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Joussen, N. Smyth, and C. Niessen, “Pathophysiology of diabetic macular edema,” Developments in Ophthalmology, vol. 39, pp. 1–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. P. S. Chan, M. Kanwar, and R. A. Kowluru, “Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory,” Journal of Diabetes and its Complications, vol. 24, no. 1, pp. 55–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. A. Kowluru, M. Kanwar, and A. Kennedy, “Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries,” Experimental Diabesity Research, vol. 2007, Article ID 21976, 7 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Vincent and S. Mohr, “Inhibition of caspase-1/interleukin-1β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia,” Diabetes, vol. 56, no. 1, pp. 224–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Joussen, S. Doehmen, M. L. Le et al., “TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations,” Molecular Vision, vol. 15, pp. 1418–1428, 2009. View at Google Scholar · View at Scopus